MRD testing promises sharper DLBCL response tracking than PET scans, cutting false positives, biopsies, and guiding therapy ...
The speakers emphasize that symptom burden can alter sequencing priorities and prompt greater integration of supportive interventions alongside tumor directed therapy. Regular symptom assessment and ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果